Achilles Corporation and Tohatsu America Corporation (TAC) announced today that Tohatsu America will assume all sales and distribution responsibilities, including after-sales services and support, of ...
LONDON, April 04, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal ...
Shares of Achilles Therapeutics plc (NASDAQ:ACHL) surged Thursday after the biotechnology firm revealed plans to discontinue its TIL-based cNeT program and close its ongoing Phase I/IIa clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results